These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34871548)

  • 21. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
    Little SF; Webster WM; Fisher DE
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-reactivity of anthrax and C2 toxin: protective antigen promotes the uptake of botulinum C2I toxin into human endothelial cells.
    Kronhardt A; Rolando M; Beitzinger C; Stefani C; Leuber M; Flatau G; Popoff MR; Benz R; Lemichez E
    PLoS One; 2011; 6(8):e23133. PubMed ID: 21850257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage.
    Kuo SR; Willingham MC; Bour SH; Andreas EA; Park SK; Jackson C; Duesbery NS; Leppla SH; Tang WJ; Frankel AE
    Microb Pathog; 2008 Jun; 44(6):467-72. PubMed ID: 18222626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
    Kelly-Cirino CD; Mantis NJ
    Infect Immun; 2009 Nov; 77(11):4859-67. PubMed ID: 19703971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
    Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.
    Taft SC; Weiss AA
    Clin Vaccine Immunol; 2008 Jan; 15(1):71-5. PubMed ID: 18032590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Glinert I; Sittner A; Shafferman A; Kobiler D
    Infect Immun; 2012 Aug; 80(8):2623-31. PubMed ID: 22585968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal Factor.
    Pentelute BL; Barker AP; Janowiak BE; Kent SB; Collier RJ
    ACS Chem Biol; 2010 Apr; 5(4):359-64. PubMed ID: 20180595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin.
    Liu S; Bugge TH; Frankel AE; Leppla SH
    Methods Mol Biol; 2009; 539():175-90. PubMed ID: 19377974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ratio of lethal and edema factors in rabbit systemic anthrax.
    Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F
    Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge.
    Banks DJ; Barnajian M; Maldonado-Arocho FJ; Sanchez AM; Bradley KA
    Cell Microbiol; 2005 Aug; 7(8):1173-85. PubMed ID: 16008584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
    Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
    J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.
    Verma M; Suryanarayana N; Tuteja U; Thavachelvam K; Rao MK; Bhargava R; Shukla S
    Toxicon; 2017 Dec; 139():58-65. PubMed ID: 28919458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
    Chvyrkova I; Zhang XC; Terzyan S
    Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality.
    Mendenhall MA; Liu S; Portley MK; O'Mard D; Fattah R; Szabo R; Bugge TH; Khillan JS; Leppla SH; Moayeri M
    Nat Microbiol; 2020 Dec; 5(12):1464-1471. PubMed ID: 32895527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.
    Langer M; Duggan ES; Booth JL; Patel VI; Zander RA; Silasi-Mansat R; Ramani V; Veres TZ; Prenzler F; Sewald K; Williams DM; Coggeshall KM; Awasthi S; Lupu F; Burian D; Ballard JD; Braun A; Metcalf JP
    Infect Immun; 2012 Dec; 80(12):4374-87. PubMed ID: 23027535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvant.
    Duverger A; Carré JM; Jee J; Leppla SH; Cormet-Boyaka E; Tang WJ; Tomé D; Boyaka PN
    J Immunol; 2010 Nov; 185(10):5943-52. PubMed ID: 20952678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
    Brossier F; Lévy M; Landier A; Lafaye P; Mock M
    Infect Immun; 2004 Nov; 72(11):6313-7. PubMed ID: 15501759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.